Jazz Pharmaceuticals (JAZZ) News Today $120.56 -3.20 (-2.59%) As of 01/3/2025 05:45 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Centre Asset Management LLC Makes New Investment in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Centre Asset Management LLC bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 75,803 shares of the specialty pharmaceutical compJanuary 3 at 10:44 AM | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Consensus Rating of "Moderate Buy" by BrokeragesJazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the fifteen ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a hold recommendation and thirteen have issued aJanuary 3 at 3:09 AM | marketbeat.comJPMorgan Chase & Co. Has $168.85 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)JPMorgan Chase & Co. decreased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 1.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,515,534 shares of the specialty pharmaceutical company's stoJanuary 1 at 3:39 AM | marketbeat.comTD Cowen Keeps Their Buy Rating on Axsome Therapeutics (AXSM)December 30, 2024 | markets.businessinsider.comPrincipal Financial Group Inc. Sells 66,821 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Principal Financial Group Inc. lessened its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 31.9% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 142,938 shares of the specialty pharmaceutical compaDecember 28, 2024 | marketbeat.comJazz Pharmaceuticals: Should Sing A Better Tune In 2025December 23, 2024 | seekingalpha.comBarclays PLC Has $4.37 Million Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Barclays PLC increased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 19.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,210 shares of the specialtyDecember 22, 2024 | marketbeat.comSanctuary Advisors LLC Buys 9,804 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Sanctuary Advisors LLC boosted its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 502.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,754 shares of the specialty pharmaceutical compaDecember 21, 2024 | marketbeat.comJazz Pharmaceuticals Shows Improved Relative Strength; Still Shy Of BenchmarkDecember 21, 2024 | msn.com22,356 Shares in Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Purchased by Public Employees Retirement System of OhioPublic Employees Retirement System of Ohio bought a new stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm bought 22,356 shares of the specialty pharmaceutical company's stock, valued at approximaDecember 18, 2024 | marketbeat.comJazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces CEO Succession PlanDecember 17, 2024 | finanznachrichten.deJazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | finanznachrichten.deJazz Pharmaceuticals (JAZZ) Gets a Buy from TD CowenDecember 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceDecember 17, 2024 | prnewswire.comJazz Pharma's Bruce Cozadd to Retire as CEODecember 17, 2024 | marketwatch.comJazz Pharmaceuticals Announces CEO Bruce Cozadd’s Retirement PlanDecember 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals CEO Bruce Cozadd to retire by end of 2025December 17, 2024 | markets.businessinsider.comJazz Pharmaceuticals Announces CEO Succession PlanDecember 16, 2024 | prnewswire.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Stock Position Raised by Franklin Resources Inc.Franklin Resources Inc. lifted its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 4.6% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,118,688 shares of the specialty pharmaceutical company's stock after aDecember 16, 2024 | marketbeat.comTeachers Retirement System of The State of Kentucky Has $2.24 Million Stock Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Teachers Retirement System of The State of Kentucky lowered its position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 81.2% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,138 sDecember 16, 2024 | marketbeat.comIs Now The Time To Put Jazz Pharmaceuticals (NASDAQ:JAZZ) On Your Watchlist?December 14, 2024 | finance.yahoo.comTruist Financial Gives a Buy Rating to Jazz Pharmaceuticals (JAZZ)December 13, 2024 | markets.businessinsider.comJazz upgraded to Overweight at Morgan Stanley after Ziihera launchDecember 13, 2024 | finance.yahoo.comJazz Pharmaceuticals Buy Rating: Strategic Advancements and Growth ProspectsDecember 12, 2024 | markets.businessinsider.comJazz Pharmaceuticals (JAZZ) Gets a Buy from JefferiesDecember 12, 2024 | markets.businessinsider.comMorgan Stanley Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to "Overweight"Morgan Stanley upgraded shares of Jazz Pharmaceuticals from an "equal weight" rating to an "overweight" rating and increased their price target for the company from $140.00 to $175.00 in a report on Thursday.December 12, 2024 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reiterated a "buy" rating and issued a $207.00 target price on shares of Jazz Pharmaceuticals in a research report on Thursday.December 12, 2024 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by State Street CorpState Street Corp lowered its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 3.5% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 1,946,273 shares of the specialty pharmaceutical company's stock after selling 71,036 shares durinDecember 12, 2024 | marketbeat.comRBC Capital Remains a Hold on Spruce Biosciences (SPRB)December 11, 2024 | markets.businessinsider.comY Intercept Hong Kong Ltd Sells 11,622 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Y Intercept Hong Kong Ltd cut its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 47.8% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,699 shares of the specialty pharmaceutical coDecember 11, 2024 | marketbeat.comJane Street Group LLC Has $14.75 Million Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Jane Street Group LLC reduced its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 40.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 132,422 shares of the specialty pharmaceuticalDecember 11, 2024 | marketbeat.comStifel Financial Corp Purchases 20,675 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Stifel Financial Corp grew its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 17.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 142,075 shares of the specialty pharmaceutical company's stoDecember 11, 2024 | marketbeat.comRBC Capital Sticks to Their Buy Rating for Jazz Pharmaceuticals (JAZZ)December 10, 2024 | markets.businessinsider.comTwo Sigma Advisers LP Buys 84,500 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Two Sigma Advisers LP increased its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 393.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 106,000 shares of the specialty pharmaceutical company's stock after aDecember 10, 2024 | marketbeat.comCBD Drug For Tuberous Sclerosis: Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And Cognitive ImprovementsDecember 9, 2024 | benzinga.comXTX Topco Ltd Raises Stock Holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)XTX Topco Ltd lifted its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 57.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 11,631 shares of the specialty pharmaceutical compDecember 9, 2024 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Given Average Rating of "Moderate Buy" by AnalystsShares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Get Free Report) have received a consensus rating of "Moderate Buy" from the fifteen analysts that are currently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold recommendation and twelve hDecember 9, 2024 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) Shares Sold by BNP Paribas Financial MarketsBNP Paribas Financial Markets lowered its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 99.7% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 16,833 shares of the specialty pharmaceutical company's stock after selling 6December 8, 2024 | marketbeat.comJazz Pharma Says NCCN Recommends Ziihera 50 Mg As CAT 2A Treatment Option For Biliary Tract CancerDecember 7, 2024 | markets.businessinsider.comQuantinno Capital Management LP Acquires 42,924 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Quantinno Capital Management LP raised its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 268.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 58,913 shares of the specialty pharmaceutical company's stock after buyDecember 7, 2024 | marketbeat.comJazz (JAZZ) Up 3.4% Since Last Earnings Report: Can It Continue?December 6, 2024 | finance.yahoo.comJazz Pharmaceuticals to Showcase New Real-World Evidence Reinforcing Epidiolex® (cannabidiol) Benefits and Broad-Spectrum Efficacy in Treatment-Resistant Epilepsies at the American Epilepsy Society 2024 Annual MeetingDecember 6, 2024 | prnewswire.comPoint72 Asset Management L.P. Grows Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Point72 Asset Management L.P. increased its position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 47.7% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 268,783 shares of the specialty phaDecember 6, 2024 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 135.3% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 174,078 shares of the speciDecember 6, 2024 | marketbeat.comFmr LLC Sells 87,943 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Fmr LLC trimmed its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 9.5% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 835,881 shares of the specialty pharmaceutical company's stock after selling 87,943 shares during theDecember 6, 2024 | marketbeat.comBank of Montreal Can Sells 49,214 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Bank of Montreal Can reduced its stake in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 71.7% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 19,447 shares of the specialty pharmaceutical company's stock afterDecember 6, 2024 | marketbeat.comJazz Pharmaceuticals’ Ziihera now included in updated NCCN guidelinesDecember 6, 2024 | markets.businessinsider.comJazz Pharmaceuticals Announces Update to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology for Biliary Tract Cancers to Include zanidatamab-hrii (Ziihera®)December 5, 2024 | prnewswire.comSystematic Financial Management LP Acquires 29,647 Shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ)Systematic Financial Management LP raised its holdings in Jazz Pharmaceuticals plc (NASDAQ:JAZZ - Free Report) by 11.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 283,977 shares of the specialty pharmaceutical companDecember 5, 2024 | marketbeat.comJazz Pharmaceuticals plc (NASDAQ:JAZZ) CEO Sells $242,340.00 in StockDecember 5, 2024 | insidertrades.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼0.760.87▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼410▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies RPRX News CORT News PRGO News SUPN News PCRX News OMER News NKTR News ASMB News CPIX News LLY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 1/4/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAZZ Stock Alerts